Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay P McLaughlin

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
ACS Central Science|September 2, 2024
Signaling Modulation Mediated by Ligand Water Interactions with the Sodium Site at μORRohini S Ople, Nokomis Ramos-Gonzalez, Qiongyu Li, et al.
Journal of Medicinal Chemistry|August 25, 2016
Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2András Váradi, Gina F Marrone, Travis C Palmer, et al.
Nature Communications|March 14, 2025
Structure-guided design of partial agonists at an opioid receptorBalazs R Varga, Sarah M Bernhard, Amal El Daibani, et al.
Elife|February 8, 2021
Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric siteRajendra Uprety, Tao Che, Saheem A Zaidi, et al.
Journal of Medicinal Chemistry|September 10, 2021
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse EffectsSoumen Chakraborty, Jeffrey F DiBerto, Abdelfattah Faouzi, et al.
Neuropharmacology|September 20, 2022
SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic miceJun Zhu, Pamela M Quizon, Yingying Wang, et al.
Journal of Medicinal Chemistry|November 16, 2021
Oxidative Metabolism as a Modulator of Kratom's Biological ActionsSoumen Chakraborty, Rajendra Uprety, Samuel T Slocum, et al.
Nature|November 30, 2022
Structure-based design of bitopic ligands for the µ-opioid receptorAbdelfattah Faouzi, Haoqing Wang, Saheem A Zaidi, et al.
ACS Chemical Neuroscience|June 26, 2025
Synthesis and Pharmacology of a Morphinan-Derived Dual Mu-Kappa Opioid Receptor Agonist AnalgesicBalazs R Varga, Rajendra Uprety, Barnali Paul, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
ACS Central Science|September 2, 2024
Signaling Modulation Mediated by Ligand Water Interactions with the Sodium Site at μORRohini S Ople, Nokomis Ramos-Gonzalez, Qiongyu Li, et al.
Journal of Medicinal Chemistry|August 25, 2016
Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2András Váradi, Gina F Marrone, Travis C Palmer, et al.
Nature Communications|March 14, 2025
Structure-guided design of partial agonists at an opioid receptorBalazs R Varga, Sarah M Bernhard, Amal El Daibani, et al.
Elife|February 8, 2021
Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric siteRajendra Uprety, Tao Che, Saheem A Zaidi, et al.
Journal of Medicinal Chemistry|September 10, 2021
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse EffectsSoumen Chakraborty, Jeffrey F DiBerto, Abdelfattah Faouzi, et al.
Neuropharmacology|September 20, 2022
SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic miceJun Zhu, Pamela M Quizon, Yingying Wang, et al.
Journal of Medicinal Chemistry|November 16, 2021
Oxidative Metabolism as a Modulator of Kratom's Biological ActionsSoumen Chakraborty, Rajendra Uprety, Samuel T Slocum, et al.
Nature|November 30, 2022
Structure-based design of bitopic ligands for the µ-opioid receptorAbdelfattah Faouzi, Haoqing Wang, Saheem A Zaidi, et al.
ACS Chemical Neuroscience|June 26, 2025
Synthesis and Pharmacology of a Morphinan-Derived Dual Mu-Kappa Opioid Receptor Agonist AnalgesicBalazs R Varga, Rajendra Uprety, Barnali Paul, et al.
Pageof 11